|
Synonyms: FZD8-Fc | OMP-54F28 | OMP54F28
Compound class:
Peptide or derivative
Comment: Ipafricept (OMP-54F28) is a fusion protein that fuses the FZD8 cysteine-rich domain to human IGHG1 Fc fragment [1]. It acts as a soluble decoy receptor for WNT ligands, and exhibits antitumour efficacy in vivo. Produced by OncoMed Pharmaceuticals.
|
Classification  |
|
| Compound class | Peptide or derivative |
| International Nonproprietary Names |
|
| INN number | INN |
| 9810 | ipafricept |
| Synonyms |
| FZD8-Fc | OMP-54F28 | OMP54F28 |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 475 |
| Other databases | |
| GtoPdb PubChem SID | 381745006 |
| Search PubMed clinical trials | ipafricept |
| Search PubMed titles | ipafricept |
| Search PubMed titles/abstracts | ipafricept |
